Perry Molinoff, M.D.
Professor or Pharmacology, University of Pennsylvania
AN Richards Professor of Pharmacology Emeritus, University of Pennsylvania
Dr. Perry Molinoff is a Professor of Pharmacology and the AN Richards Professor of Pharmacology Emeritus at the University of Pennsylvania. He returned to a faculty position in the School of Medicine in July, 2007 after serving for three years as the Vice Provost for Research of the University of Pennsylvania.
As the Vice Provost for Research, Dr. Molinoff had oversight responsibility for the University’s policies and procedures that promote research excellence across the University and for management of key elements of the research infrastructure including infrastructure relating to grants, human and animal research compliance, animal care, environmental health and radiation safety, and conflict of interest and research misconduct. Dr. Molinoff developed linkages between the University and industry and was responsible for the transfer of technologies from university laboratories to the public sector for commercial application. Additionally, Dr. Molinoff provided leadership and coordination of multidisciplinary research programs and represented Penn to local and regional constituencies as well as to federal and other funding agencies. The University of Pennsylvania’s research enterprise had over $700 million in research awards during his term.
Dr. Molinoff's background includes more than thirty years of experience in both the academic and industrial sectors. From 1981 through 1994, he was the A.N. Richards Professor of Pharmacology and Chairman of the Department of Pharmacology at the University of Pennsylvania. Research in his laboratory focused on the molecular pharmacology of receptors and signal recognition. Prior to returning to Penn in 2003, he was the Executive Vice President of Research and Development at Palatin Technologies. Reporting to the CEO, he oversaw Palatin's research and clinical operations and helped to steer the company's products through preclinical and clinical stages toward commercialization. From 1995 through 2000, Dr. Molinoff was Vice President of Neuroscience and Genitourinary Drug Discovery for the Bristol-Meyers Squibb Pharmaceutical Research Institute. In this position, he directed and implemented the Institute's research efforts in these areas. Clinical candidates were identified for treatment of sleep disorders, schizophrenia, stroke, Parkinson’s Disease, Alzheimer’s Disease, incontinence and sexual dysfunction.
Dr. Molinoff serves or has served on the Board of Directors of both public and private companies including Cypress Bioscience and Palatin Technologies. He is a member of the Scientific Advisory Board of Advinus Therapeutics, an Indian pharmaceutical company and is a part time consultant for Galleon Pharmaceuticals. He has served on multiple editorial advisory boards for scientific and educational journals. He authored or edited six books including 2 editions of Basic Neurochemistry, and the 9th edition of Goodman and Gilman’s The Pharmacological Basis of Therapeutics, as well as over 230 manuscripts. Dr. Molinoff earned his undergraduate and medical degrees from Harvard University and completed house officer’s training at the University of Chicago’s Hospitals and Clinics.